{"organizations": [], "uuid": "576a48057ea835422f0d55ef6ede1d916c84a321", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180111.html", "section_title": "Archive News &amp; Video for Thursday, 11 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-hangzhou-tianmushan-pharmaceutical/brief-hangzhou-tianmushan-pharmaceutical-enterprise-unit-obtains-high-tech-enterprise-recognition-again-idUSL4N1P62ZH", "country": "US", "domain_rank": 408, "title": "BRIEF-Hangzhou TianMuShan Pharmaceutical Enterprise unit obtains high-tech enterprise recognition again", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.919, "site_type": "news", "published": "2018-01-11T16:32:00.000+02:00", "replies_count": 0, "uuid": "576a48057ea835422f0d55ef6ede1d916c84a321"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-hangzhou-tianmushan-pharmaceutical/brief-hangzhou-tianmushan-pharmaceutical-enterprise-unit-obtains-high-tech-enterprise-recognition-again-idUSL4N1P62ZH", "ord_in_thread": 0, "title": "BRIEF-Hangzhou TianMuShan Pharmaceutical Enterprise unit obtains high-tech enterprise recognition again", "locations": [], "entities": {"persons": [], "locations": [{"name": "beijing", "sentiment": "none"}], "organizations": [{"name": "hangzhou tianmushan pharmaceutical enterprise co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "tianmushan pharmaceutical enterprise", "sentiment": "negative"}, {"name": "thomson reuters trust principles", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 11 (Reuters) - Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd\n* Says Huangshan-based pharmaceutical unit was recognized as high-tech enterprise again and could enjoy a tax preference of 15 percent, from 2017 to 2019\nSource text in Chinese: goo.gl/z6tm3b\nFurther company coverage: (Beijing Headline News)\nOur Standards: The Thomson Reuters Trust Principles.", "external_links": ["https://goo.gl/z6tm3b", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-11T16:32:00.000+02:00", "crawled": "2018-01-12T18:35:25.006+02:00", "highlightTitle": ""}